Sex-Aware Meta-Analysis of the Gut Microbiome in Alzheimer's Disease: Intersections of Steroid Metabolism and Neuroinflammation
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Alzheimer’s Disease (AD) exhibits a profound biological sex bias, with females experiencing higher prevalence and more severe pathological progression. Emerging evidence suggests the gut-brain-endocrine axis—specifically the "estrobolome"—serves as a critical mediator of these disparities. This project presents a large-scale, systematic meta-analysis of publicly available human gut microbiome datasets (16S rRNA, Shotgun WGS, and Long-Read Sequencing) to elucidate the mechanistic links between microbial steroid metabolism, host genetics, and AD. By aggregating raw data from cohorts, we aim to i) identify sex-specific microbial signatures associated with late-onset AD, ii) quantify the functional potential of the estrobolome and progestobolome (including beta-glucuronidase and beta-HSD genes) using a multi-omic integration pipeline. Our methodology adheres to PRISMA 2026 guidelines, utilizing a uniform bioinformatic re-processing workflow (DADA2 for 16S; MetaPhlAn/HUMAnN for WGS) to mitigate batch effects across disparate platforms. By stratifying our analysis by biological sex, this study seeks to define the gender-specific microbial elements as predictive and therapeutic targets. Ultimately, this research contributes to the development of precision, sex-specific interventions aimed at mitigating neuroinflammation through gut microbiome modulation.
Fields of Study & Subjects
Gut microbiota and health
Alzheimer's disease research and treatments
Dementia and Cognitive Impairment Research
Publication details
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Preprint